NVNO enVVeno Medical Corporation

8.200USD+2.37%Mkt Cap: 5.70M $P/E: —

enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The compa…

Key Statistics

Company
Market Cap5.70M USD
Enterprise Value-15.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.47M USD
Revenue/Share—
Last Price8.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees33
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.32
PEG—
EV/EBITDA0.89
EV/Revenue—
P/S—
P/B0.27
EPS (TTM)-24.99
EPS (Forward)-6.22
52W Range
7.0104% of range35.70
52W High35.70 USD
52W Low7.010 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-71.77%
ROA-65.87%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.57M USD
CapEx (TTM)5.00K USD
FCF Margin—
FCF Yield-168.33%
Net Debt-20.98M USD
Net Debt/EBITDA1.22
Balance Sheet
Debt/Equity0.03
Current Ratio11.70
Quick Ratio11.39
Book Value/Sh30.71 USD
Cash/Share31.47 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateNov 30, 2020
Splits
Last Split1:35
Split DateJan 20, 2026
Analyst Consensus
Rating—
Target (Mean)30.00 USD
Upside (mean)+265.9%
Target Range30.00 USD – 30.00 USD
# Analysts1
Ownership
Shares Out.694.83K
Float590.41K
Insiders8.23%
Institutions15.96%
Short Interest
Short Ratio0.3d
Short % Float1.36%
Short % Out.1.35%
Shares Short9.38K
Short (prev mo.)24.40K
Technical
SMA 5010.19 (-19.5%)
SMA 20010.73 (-23.6%)
Beta1.29
S&P 52W Chg16.45%
Avg Vol (30d)25.40K
Avg Vol (10d)20.12K
Technical Indicators
RSI (14)35.3
MACD-0.6867
MACD Signal-0.5922
MACD Hist.-0.0945
BB Upper11.67 USD
BB Middle9.288 USD
BB Lower6.906 USD
BB Width51.30%
ATR (14)0.7739 USD
Vol Ratio (20d)1.27x